|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.030 USD | -3.25% |
|
-.--% | -32.29% |
| 06-22 | Arvinas, Inc. Announces Resignation of Noah Berkowitz from Chief Medical Officer, Effective July 3, 2026 | CI |
| 06-16 | Rigel Pharmaceuticals Closes Licensing Deal for Breast Cancer Drug Veppanu | MT |
| Market Cap | 518M 450M 419M 385M 727M 49.46B 738M 4.94B 1.94B 24.62B 1.95B 1.9B 82.56B | P/E 2026 * |
-2.98x | P/E 2027 * | -2.25x |
|---|---|---|---|---|---|
| Enterprise Value | 14.1M 12.26M 11.41M 10.48M 19.79M 1.35B 20.09M 135M 52.79M 670M 52.97M 51.8M 2.25B | EV / Sales 2026 * |
0.11x | EV / Sales 2027 * | 3.42x |
| Free-Float |
79.74% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arvinas, Inc.
| 1 day | -3.25% | ||
| 1 month | -2.07% | ||
| 3 months | -23.60% | ||
| 6 months | -39.99% | ||
| Current year | -32.29% |
| 1 week | 7.9 |  | 8.37 |
| 1 month | 7.9 | | 8.9 |
| Current year | 6.97 | | 14.51 |
| 1 year | 6.06 | | 14.51 |
| 3 years | 5.9 | | 53.08 |
| 5 years | 5.9 | | 103.53 |
| 10 years | 5.9 | | 108.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Randy Teel
CEO | Chief Executive Officer | 47 | 2026-02-11 |
Andrew Saik
DFI | Director of Finance/CFO | 56 | 2024-06-23 |
Angela Cacace
CTO | Chief Tech/Sci/R&D Officer | 58 | 2024-06-16 |
| Director | Title | Age | Since |
|---|---|---|---|
John Houston
CHM | Chairman | 66 | 2023-06-14 |
Edward Kennedy
BRD | Director/Board Member | 64 | 2018-06-30 |
Briggs Morrison
CHM | Chairman | 67 | 2026-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/6/26 | Buy | Chairman | 20,000 | 0.0313% | ||
| 2/27/26 | Sell | Director | 35,297 | 0.0550% | ||
| 2/26/26 | Free | Controller/Auditor | 30,924 | 0.0482% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.25% | -.--% | +8.22% | -67.70% | 518M | |
| +2.35% | +2.74% | +38.10% | +71.29% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +61.15% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -15.45% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +345.55% | 21.37B | |
| +2.49% | -0.92% | +23.57% | -13.14% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -31.95% | 17.56B | |
| +0.58% | -5.88% | +19.40% | +527.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +278.22% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +170.15% | 13.33B | |
| Average | -0.44% | -3.41% | +33.10% | +132.56% | 23.44B | |
| Weighted average by Cap. | +0.22% | -2.95% | +30.74% | +116.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 112M 104M 95.79M 181M 12.31B 184M 1.23B 483M 6.13B 484M 474M 20.55B | 72.4M 62.94M 58.58M 53.79M 102M 6.91B 103M 691M 271M 3.44B 272M 266M 11.54B |
| Net income | -175M -152M -142M -130M -246M -16.72B -250M -1.67B -656M -8.33B -658M -643M -27.92B | -249M -217M -202M -185M -350M -23.79B -355M -2.38B -933M -11.84B -936M -915M -39.71B |
| Net Debt | -504M -438M -408M -374M -707M -48.11B -718M -4.81B -1.89B -23.95B -1.89B -1.85B -80.32B | -270M -235M -219M -201M -379M -25.79B -385M -2.58B -1.01B -12.84B -1.01B -993M -43.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$8.030 | -3.25% | 687,895 |
| 26-07-30 | US$8.300 | +0.97% | 550,055 |
| 26-07-29 | US$8.220 | +0.24% | 740,473 |
| 26-07-28 | US$8.200 | -0.24% | 551,915 |
| 26-07-27 | US$8.220 | +2.37% | 475,559 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARVN Stock
Select your edition
All financial news and data tailored to specific country editions
